Amneal Outlines Ambitions To Become Leading Affordable Medicines Supplier In US
American Business Sits At Around $1.5bn And Growing
While it currently sits in fourth place, Amneal’s co-CEO Chirag Patel has laid out ambitions for the firm to become the number one supplier of affordable medicines in the US.
